Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Teladoc Health, Inc.TDOC · Entity 1547 | CHIEF LEGAL OFFICER, SECRETARY | September 01, 2026 | September 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Teladoc Health, Inc.
Report date September 01, 2026 · Filed September 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 117,616 |
Ending reported balance
After 2026-09-02 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-09-01 · Exercise / conversion · Acquired 5,350 · Balance 115,611 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Row 2 · 2026-09-01 · Exercise / conversion · Acquired 9,152 · Balance 124,763 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Row 3 · 2026-09-01 · Exercise / conversion · Acquired 426 · Balance 125,189 F2: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Row 4 · 2026-09-02 · Sale · Disposed 7,573 · Balance 117,616 F3: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 10,700 |
Reported balance
After 2026-09-01 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-09-01 · Exercise / conversion · Disposed 5,350 · Balance 10,700 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F4: On March 19, 2024, the reporting person was granted 64,200 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 54,918 |
Reported balance
After 2026-09-01 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-09-01 · Exercise / conversion · Disposed 9,152 · Balance 54,918 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5: On March 1, 2025, the reporting person was granted 109,832 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,553 |
Reported balance
After 2026-09-01 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-09-01 · Exercise / conversion · Disposed 426 · Balance 2,553 F2: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F6: On March 1, 2026, the reporting person earned 5,107 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2: Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F3: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F4: On March 19, 2024, the reporting person was granted 64,200 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.
F5: On March 1, 2025, the reporting person was granted 109,832 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F6: On March 1, 2026, the reporting person earned 5,107 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 02, 2026 Filed Sep 3, 2026 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 7,573 | $6.30 | $47,717.47 |
DisclosureSEC source: 0001375088-26-000006 · wk-form4_1788465953.xml · nonDerivative · entry 4 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,616 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 426 | $0.00 | $0.00 |
DisclosureSEC source: 0001375088-26-000006 · wk-form4_1788465953.xml · derivative · entry 7 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,553 Underlying: Common Stock · 426 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F6 · derivative.exercise_date: On March 1, 2026, the reporting person earned 5,107 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. F6 · derivative.expiration_date: On March 1, 2026, the reporting person earned 5,107 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 9,152 | $0.00 | $0.00 |
DisclosureSEC source: 0001375088-26-000006 · wk-form4_1788465953.xml · derivative · entry 6 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,918 Underlying: Common Stock · 9,152 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 1, 2025, the reporting person was granted 109,832 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. F5 · derivative.expiration_date: On March 1, 2025, the reporting person was granted 109,832 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 5,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001375088-26-000006 · wk-form4_1788465953.xml · derivative · entry 5 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,700 Underlying: Common Stock · 5,350 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 19, 2024, the reporting person was granted 64,200 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. F4 · derivative.expiration_date: On March 19, 2024, the reporting person was granted 64,200 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 426 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001375088-26-000006 · wk-form4_1788465953.xml · nonDerivative · entry 3 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,189 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 9,152 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001375088-26-000006 · wk-form4_1788465953.xml · nonDerivative · entry 2 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 5,350 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001375088-26-000006 · wk-form4_1788465953.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,611 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| June 02, 2026 Filed Jun 3, 2026 20:25 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 7,906 | $7.63 | $60,299.06 |
DisclosureSEC source: 0001375088-26-000004 · wk-form4_1780518314.xml · nonDerivative · entry 4 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,261 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:25 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 9,152 | $0.00 | $0.00 |
DisclosureSEC source: 0001375088-26-000004 · wk-form4_1780518314.xml · derivative · entry 7 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,070 Underlying: Common Stock · 9,152 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F7 · derivative.exercise_date: On March 1, 2025, the reporting person was granted 109,832 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. F7 · derivative.expiration_date: On March 1, 2025, the reporting person was granted 109,832 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:25 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 5,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001375088-26-000004 · wk-form4_1780518314.xml · derivative · entry 6 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,050 Underlying: Common Stock · 5,350 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F6 · derivative.exercise_date: On March 19, 2024, the reporting person was granted 64,200 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. F6 · derivative.expiration_date: On March 19, 2024, the reporting person was granted 64,200 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:25 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 426 | $0.00 | $0.00 |
DisclosureSEC source: 0001375088-26-000004 · wk-form4_1780518314.xml · derivative · entry 5 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,979 Underlying: Common Stock · 426 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: The performance stock units vest as to one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. F4 · derivative.expiration_date: The performance stock units vest as to one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. F5 · derivative.underlying_shares: On March 1, 2026, the reporting person earned 5,107 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:25 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 9,152 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001375088-26-000004 · wk-form4_1780518314.xml · nonDerivative · entry 3 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,167 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:25 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 5,350 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001375088-26-000004 · wk-form4_1780518314.xml · nonDerivative · entry 2 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,015 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:25 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 426 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001375088-26-000004 · wk-form4_1780518314.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,665 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 27,083 | $5.12 | $138,583.71 |
DisclosureSEC source: 0001375088-26-000002 · wk-form4_1772572282.xml · nonDerivative · entry 6 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,239 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 181,661 | $0.00 | $0.00 |
DisclosureSEC source: 0001375088-26-000002 · wk-form4_1772572282.xml · derivative · entry 13 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 181,661 Underlying: Common Stock · 181,661 shares Expires not disclosed F12 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F13 · derivative.exercise_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F13 · derivative.expiration_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 1,702 | $0.00 | $0.00 |
DisclosureSEC source: 0001375088-26-000002 · wk-form4_1772572282.xml · derivative · entry 12 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,405 Underlying: Common Stock · 1,702 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F11 · derivative.exercise_date: On March 1, 2026, the reporting person earned 5,107 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. F11 · derivative.expiration_date: On March 1, 2026, the reporting person earned 5,107 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantPerformance Stock Units · Derivative | 5,107 | $0.00 | $0.00 |
DisclosureSEC source: 0001375088-26-000002 · wk-form4_1772572282.xml · derivative · entry 11 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,107 Underlying: Common Stock · 5,107 shares Expires not disclosed F8 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock. F9 · shares: Performance award amount determined based on metrics in respect of the issuer's 2025 financial results. F10 · derivative.exercise_date: The performance stock units vest as to one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. F10 · derivative.expiration_date: The performance stock units vest as to one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 1,510 | $0.00 | $0.00 |
DisclosureSEC source: 0001375088-26-000002 · wk-form4_1772572282.xml · derivative · entry 10 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,510 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F7 · derivative.exercise_date: On March 1, 2024, the reporting person earned 18,067 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F7 · derivative.expiration_date: On March 1, 2024, the reporting person earned 18,067 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 36,610 | $0.00 | $0.00 |
DisclosureSEC source: 0001375088-26-000002 · wk-form4_1772572282.xml · derivative · entry 9 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,222 Underlying: Common Stock · 36,610 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F6 · derivative.exercise_date: On March 1, 2025, the reporting person was granted 109,832 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. F6 · derivative.expiration_date: On March 1, 2025, the reporting person was granted 109,832 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 5,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001375088-26-000002 · wk-form4_1772572282.xml · derivative · entry 8 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,400 Underlying: Common Stock · 5,350 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 19, 2024, the reporting person was granted 64,200 restricted stock units, vesting one-third on March 19, 2025, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. F5 · derivative.expiration_date: On March 19, 2024, the reporting person was granted 64,200 restricted stock units, vesting one-third on March 19, 2025, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 4,418 | $0.00 | $0.00 |
DisclosureSEC source: 0001375088-26-000002 · wk-form4_1772572282.xml · derivative · entry 7 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,418 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 3, 2023, the reporting person was granted 53,013 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F4 · derivative.expiration_date: On March 3, 2023, the reporting person was granted 53,013 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,702 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001375088-26-000002 · wk-form4_1772572282.xml · nonDerivative · entry 5 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,322 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,510 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001375088-26-000002 · wk-form4_1772572282.xml · nonDerivative · entry 4 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,620 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 36,610 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001375088-26-000002 · wk-form4_1772572282.xml · nonDerivative · entry 3 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,110 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 5,350 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001375088-26-000002 · wk-form4_1772572282.xml · nonDerivative · entry 2 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 4,418 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001375088-26-000002 · wk-form4_1772572282.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,150 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| December 02, 2025 Filed Dec 4, 2025 02:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 5,720 | $7.49 | $42,831.36 |
DisclosureSEC source: 0001375088-25-000004 · wk-form4_1764813842.xml · nonDerivative · entry 4 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,732 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 02:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 5,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001375088-25-000004 · wk-form4_1764813842.xml · derivative · entry 7 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,750 Underlying: Common Stock · 5,350 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F7 · derivative.exercise_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. F7 · derivative.expiration_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 02:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 4,418 | $0.00 | $0.00 |
DisclosureSEC source: 0001375088-25-000004 · wk-form4_1764813842.xml · derivative · entry 6 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,418 Underlying: Common Stock · 4,418 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 3, 2023, the reporting person was granted 53,013 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F5 · derivative.expiration_date: On March 3, 2023, the reporting person was granted 53,013 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 02:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 1,505 | $0.00 | $0.00 |
DisclosureSEC source: 0001375088-25-000004 · wk-form4_1764813842.xml · derivative · entry 5 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,510 Underlying: Common Stock · 1,505 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F4 · derivative.expiration_date: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 02:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 5,350 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001375088-25-000004 · wk-form4_1764813842.xml · nonDerivative · entry 3 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,452 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 02:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 4,418 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001375088-25-000004 · wk-form4_1764813842.xml · nonDerivative · entry 2 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,102 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 02:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,505 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001375088-25-000004 · wk-form4_1764813842.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,684 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| September 02, 2025 Filed Sep 3, 2025 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 5,867 | $7.59 | $44,501.20 |
DisclosureSEC source: 0001477449-25-000107 · wk-form4_1756929931.xml · nonDerivative · entry 4 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,179 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| August 29, 2025 Filed Sep 3, 2025 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 5,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-25-000107 · wk-form4_1756929931.xml · derivative · entry 7 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,100 Underlying: Common Stock · 5,350 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F6 · derivative.exercise_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. F6 · derivative.expiration_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. Read SEC document |
| August 29, 2025 Filed Sep 3, 2025 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 4,418 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-25-000107 · wk-form4_1756929931.xml · derivative · entry 6 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,836 Underlying: Common Stock · 4,418 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 3, 2023, the reporting person was granted 53,013 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F5 · derivative.expiration_date: On March 3, 2023, the reporting person was granted 53,013 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| August 29, 2025 Filed Sep 3, 2025 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 1,505 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-25-000107 · wk-form4_1756929931.xml · derivative · entry 5 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,015 Underlying: Common Stock · 1,505 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F4 · derivative.expiration_date: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| August 29, 2025 Filed Sep 3, 2025 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 5,350 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-25-000107 · wk-form4_1756929931.xml · nonDerivative · entry 3 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,046 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| August 29, 2025 Filed Sep 3, 2025 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 4,418 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-25-000107 · wk-form4_1756929931.xml · nonDerivative · entry 2 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,696 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| August 29, 2025 Filed Sep 3, 2025 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,505 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-25-000107 · wk-form4_1756929931.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,278 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| June 02, 2025 Filed Jun 3, 2025 21:37 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 5,808 | $6.86 | $39,842.88 |
DisclosureSEC source: 0001477449-25-000083 · wk-form4_1748986620.xml · nonDerivative · entry 4 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,773 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 21:37 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 5,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-25-000083 · wk-form4_1748986620.xml · derivative · entry 7 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,450 Underlying: Common Stock · 5,350 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F6 · derivative.exercise_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. F6 · derivative.expiration_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 21:37 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 4,418 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-25-000083 · wk-form4_1748986620.xml · derivative · entry 6 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,254 Underlying: Common Stock · 4,418 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 3, 2023, the reporting person was granted 53,013 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F5 · derivative.expiration_date: On March 3, 2023, the reporting person was granted 53,013 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 21:37 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 1,505 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-25-000083 · wk-form4_1748986620.xml · derivative · entry 5 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,520 Underlying: Common Stock · 1,505 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F4 · derivative.expiration_date: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 21:37 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 5,350 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-25-000083 · wk-form4_1748986620.xml · nonDerivative · entry 3 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,581 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 21:37 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 4,418 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-25-000083 · wk-form4_1748986620.xml · nonDerivative · entry 2 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,231 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 21:37 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,505 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-25-000083 · wk-form4_1748986620.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,813 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 28, 2025 Filed Mar 4, 2025 21:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 4,418 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-25-000016 · wk-form4_1741122364.xml · nonDerivative · entry 2 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,349 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 20, 2025 Filed Mar 21, 2025 20:20 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 11,011 | $8.42 | $92,756.66 |
DisclosureSEC source: 0001477449-25-000034 · wk-form4_1742588409.xml · nonDerivative · entry 2 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,308 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.